Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade.
Alblihy A, Ali R, Algethami M, Ritchie AA, Shoqafi A, Alqahtani S, Mesquita KA, Toss MS, Ordóñez-Morán P, Jeyapalan JN, Dekker L, Salerno M, Hartsuiker E, Grabowska AM, Rakha EA, Mongan NP, Madhusudan S.
Alblihy A, et al. Among authors: ordonez moran p.
Int J Mol Sci. 2023 Jun 30;24(13):10966. doi: 10.3390/ijms241310966.
Int J Mol Sci. 2023.
PMID: 37446144
Free PMC article.